VAS
RVMD icon

Vestmark Advisory Solutions’s Revolution Medicines RVMD Stock Holding History

Vestmark Advisory Solutions’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$618K Buy
+3,298
New +$482K 0.01% 1094

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Vestmark Advisory Solutions's RVMD Position: Q2 2026 in Review

Vestmark Advisory Solutions opened a new position in Revolution Medicines (RVMD) in Q2 2026: 3,298 shares worth $618K. The stake represents 0.01% of the portfolio and ranks #1094 among its holdings.

689 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • Vestmark Advisory Solutions held 3,298 shares of Revolution Medicines worth $618K as of Q2 2026.
  • Revolution Medicines was a new Vestmark Advisory Solutions position in Q2 2026.
  • Revolution Medicines made up 0.01% of Vestmark Advisory Solutions's portfolio in Q2 2026, its #1094 holding.
  • 689 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on Vestmark Advisory Solutions's 13F filing for Q2 2026, filed 14 Aug 2026.